NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI ® (encorafenib) in combination with cetuximab ...
Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report delivers extensive insights into ...
Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "TIGIT Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report presents in-depth insights into more than ...
Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "JAK Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report delivers a detailed analysis of over 40 ...
(MENAFN- GlobeNewsWire - Nasdaq) The JAK inhibitors market offers significant opportunities in treating autoimmune and rheumatic diseases through diverse product development by over 40 companies and ...
Spyre Therapeutics, Inc. earns a Strong Buy on Phase 1 wins, IBD/RA pipeline catalysts, and $757M cash runway. Click for this ...
RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ -- TIME has named Cindy Eckert, Founder and CEO of Sprout Pharmaceuticals, makers of Addyi®, to the 2026 TIME100 Health list recognizing the world's most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results